Establishing reliable criteria for isolating myogenic cell fractions with stem cell properties and enhanced regenerative capacity

Blood Cells, Molecules, and Diseases

Volumn 32, Issue 1, 2004, Pages 24-33

  Jankowski, Ron J ^a,b   Huard, Johnny ^a,b,c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Myogenic cell fractions; Regenerative capacity; Stem cell property

Indexed keywords

DESMIN; DYSTROPHIN;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL FRACTIONATION; CELL FUNCTION; CELL ISOLATION; CELL POPULATION; CELL PROLIFERATION; CELL TRANSPLANTATION; CONTROLLED STUDY; CORRELATION ANALYSIS; EVALUATION; FEMALE; MEDICAL RESEARCH; MUSCLE DEVELOPMENT; NONHUMAN; PRIORITY JOURNAL; PURIFICATION; RAT; STEM CELL;

ANIMALIA;

EID: 0742272112     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcmd.2003.09.012     Document Type: Article

References (58)

1. Jankowski R.J., Deasy B.M., Cao B., Gates C., Huard J. The role of CD34 expression and cellular fusion in the regeneration capacity of myogenic progenitor cells. J. Cell Sci. 115:2002;4361-4374.
2. Menasche P., Hagege A.A., Vilquin J.T., Desnos M., Abergel E., Pouzet B., Bel A., Sarateanu S., Scorsin M., Schwartz K.et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J. Am. Coll. Cardiol. 41:2003;1078-1083.
3. Pagani F.D., DerSimonian H., Zawadzka A., Wetzel K., Edge A.S., Jacoby D.B., Dinsmore J.H., Wright S., Aretz T.H., Eisen H.J.et al. Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation. J. Am. Coll. Cardiol. 41:2003;879-888.
4. Hoffman E.P., Brown R.H., Kunkel L.M. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Biotechnology. 24:1992;457-466.
5. Mendell J.R., Kissel J.T., Amato A.A., King W., Signore L., Prior T.W., Sahenk Z., Benson S., McAndrew P.E., Rice R.et al. Myoblast transfer in the treatment of Duchenne's muscular dystrophy. N. Engl. J. Med. 333:1995;832-838.
6. Gussoni E., Pavlath G.K., Lanctot A.M., Sharma K.R., Miller R.G., Steinman L., Blau H.M. Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation. Nature. 356:1992;435-438.
7. Huard J., Bouchard J.P., Roy R., Malouin F., Dansereau G., Labrecque C., Albert N., Richards C.L., Lemieux B., Tremblay J.P. Human myoblast transplantation: preliminary results of 4 cases. Muscle Nerve. 15:1992;550-560.
8. Miller R.G., Sharma K.R., Pavlath G.K., Gussoni E., Mynhier M., Lanctot A.M., Greco C.M., Steinman L., Blau H.M. Myoblast implantation in Duchenne muscular dystrophy: the San Francisco study. Muscle Nerve. 20:1997;469-478.
9. Ohtsuka Y., Udaka K., Yamashiro Y., Yagita H., Okumura K. Dystrophin acts as a transplantation rejection antigen in dystrophin-deficient mice: implication for gene therapy. J. Immunol. 160:1998;4635-4640.
10. Huard J., Acsadi G., Jani A., Massie B., Karpati G. Gene transfer into skeletal muscles by isogenic myoblasts. Hum. Gene Ther. 5:1994;949-958.
11. Tremblay J.P., Malouin F., Roy R., Huard J., Bouchard J.P., Satoh A., Richards C.L. Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy. Cell Transplant. 2:1993;99-112.
12. Morgan J.E., Hoffman E.P., Partridge T.A. Normal myogenic cells from newborn mice restore normal histology to degenerating muscles of the mdx mouse. J. Cell Biol. 111:1990;2437-2449.
13. Neumeyer A.M., Cros D., McKenna-Yasek D., Zawadzka A., Hoffman E.P., Pegoraro E., Hunter R.G., Munsat T.L., Brown R.H. Jr. Pilot study of myoblast transfer in the treatment of Becker muscular dystrophy. Neurology. 51:1998;589-592.
14. Huard J., Roy R., Bouchard J.P., Malouin F., Richards C.L., Tremblay J.P. Human myoblast transplantation between immunohistocompatible donors and recipients produces immune reactions. Transplant. Proc. 24:1992;3049-3051.
15. Tremblay J.P., Bouchard J.P., Malouin F., Theau D., Cottrell F., Collin H., Rouche A., Gilgenkrantz S., Abbadi N., Tremblay M.et al. Myoblast transplantation between monozygotic twin girl carriers of Duchenne muscular dystrophy. Neuromuscul. Disord. 3:1993;583-592.
16. Fan Y., Maley M., Beilharz M., Grounds M. Rapid death of injected myoblasts in myoblast transfer therapy. Muscle Nerve. 19:1996;853-860.
17. Beauchamp J.R., Morgan J.E., Pagel C.N., Partridge T.A. Quantitative studies of efficacy of myoblast transplantation. Muscle Nerve. 18:1994;261. (Suppl.).
18. Beauchamp J.R., Morgan J.E., Pagel C.N., Partridge T.A. Dynamics of myoblast transplantation reveal a discrete minority of precursors with stem cell-like properties as the myogenic source. J. Cell Biol. 144:1999;1113-1122.
19. Kinoshita I., Huard J., Tremblay J.P. Utilization of myoblasts from transgenic mice to evaluate the efficacy of myoblast transplantation. Muscle Nerve. 17:1994;975-980.
20. Guerette B., Asselin I., Skuk D., Entman M., Tremblay J.P. Control of inflammatory damage by anti-LFA-1: increase success of myoblast transplantation. Cell Transplant. 6:1997;101-107.
21. Cossu G., Mavilio F. Myogenic stem cells for the therapy of primary myopathies: wishful thinking or therapeutic perspective? J. Clin. Invest. 105:2000;1669-1674.
22. Smythe G.M., Hodgetts S.I., Grounds M.D. Problems and solutions in myoblast transfer therapy. J. Cell. Mol. Med. 5:2001;33-47.
23. Hodgetts S.I., Beilharz M.W., Scalzo A.A., Grounds M.D. Why do cultured transplanted myoblasts die in vivo? DNA quantification shows enhanced survival of donor male myoblasts in host mice depleted of CD4+ and CD8+ cells or Nk1.1+ cells. Cell Transplant. 9:2000;489-502.
24. Merly F., Huard C., Asselin I., Robbins P.D., Tremblay J.P. Anti-inflammatory effect of transforming growth factor-beta1 in myoblast transplantation. Transplantation. 65:1998;793-799.
25. Qu Z., Balkir L., van Deutekom J.C., Robbins P.D., Pruchnic R., Huard J. Development of approaches to improve cell survival in myoblast transfer therapy. J. Cell Biol. 142:1998;1257-1267.
26. Partridge T. The current status of myoblast transfer. Neurol. Sci. 21:2000;S939-S942.
27. Jankowski R.J., Haluszczak C., Trucco M., Huard J. Flow cytometric characterization of myogenic cell populations obtained via the preplate technique: potential for rapid isolation of muscle-derived stem cells. Hum. Gene Ther. 12:2000;619-628.
28. Seale P., Rudnicki M.A. A new look at the origin, function, and "stem-cell" status of muscle satellite cells. Dev. Biol. 218:2000;115-124.
29. Zammit P., Beauchamp J. The skeletal muscle satellite cell: stem cell or son of stem cell? Differentiation. 68:2001;193-204.
30. Deasy B.M., Huard J. Gene therapy and tissue engineering based on muscle-derived stem cells. Curr. Opin. Mol. Ther. 4:2002;382-389.
31. Qu-Petersen Z., Deasy B., Jankowski R., Ikezawa M., Cummins J., Pruchnic R., Mytinger J., Cao B., Gates C., Wernig A.et al. Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration. J. Cell Biol. 157:2002;851-864.
32. Yoshida N., Yoshida S., Koishi K., Masuda K., Nabeshima Y. Cell heterogeneity upon myogenic differentiation: down-regulation of MyoD and Myf-5 generates 'reserve cells'. J. Cell Sci. 111(Pt. 6):1998;769-779.
33. Rantanen J., Hurme T., Lukka R., Heino J., Kalimo H. Satellite cell proliferation and the expression of myogenin and desmin in regenerating skeletal muscle: evidence for two different populations of satellite cells. Lab. Invest. 72:1995;341-347.
34. Schultz E. Satellite cell proliferative compartments in growing skeletal muscles. Dev. Biol. 175:1996;84-94.
35. Baroffio A., Bochaton-Piallat M.L., Gabbiani G., Bader C.R. Heterogeneity in the progeny of single human muscle satellite cells. Differentiation. 59:1995;259-268.
36. Baroffio A., Hamann M., Bernheim L., Bochaton-Piallat M.L., Gabbiani G., Bader C.R. Identification of self-renewing myoblasts in the progeny of single human muscle satellite cells. Differentiation. 60:1996;47-57.
37. Molnar G., Ho M.L., Schroedl N.A. Evidence for multiple satellite cell populations and a non-myogenic cell type that is regulated differently in regenerating and growing skeletal muscle. Tissue Cell. 28:1996;547-556.
38. Richler C., Yaffe D. The in vitro cultivation and differentiation capacities of myogenic cell lines. Dev. Biol. 23:1970;1-22.
39. Rando T.A., Blau H.M. Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy. J. Cell Biol. 125:1994;1275-1287.
40. Qu Z., Huard J. Matching host muscle and donor myoblasts for myosin heavy chain improves myoblast transfer therapy. Gene Ther. 7:2000;428-437.
41. Carlsson L., Thornell L.E. Desmin-related myopathies in mice and man. Acta Physiol. Scand. 171:2001;341-348.
42. Greenberger J.S., Goff J.P., Bush J., Bahnson A., Koebler D., Athanassiou H., Domach M., Houck R.K. Expansion of hematopoietic stem cells in vitro as a model system for human tissue engineering. Orthop. Clin. North Am. 31:2000;499-510.
43. Deasy B.M., Qu-Peterson Z., Greenberger J.S., Huard J. Mechanisms of muscle stem cell expansion with cytokines. Stem Cells. 20:2002;50-60.
44. Cossu G., Zani B., Coletta M., Bouche M., Pacifici M., Molinaro M. In vitro differentiation of satellite cells isolated from normal and dystrophic mammalian muscles. A comparison with embryonic myogenic cells. Cell Differ. 9:1980;357-368.
45. Sabourin L.A., Girgis-Gabardo A., Seale P., Asakura A., Rudnicki M.A. Reduced differentiation potential of primary MyoD-/- myogenic cells derived from adult skeletal muscle. J. Cell Biol. 144:1999;631-643.
46. Simmons D.L., Satterthwaite A.B., Tenen D.G., Seed B. Molecular cloning of a cDNA encoding CD34, a sialomucin of human hematopoietic stem cells. J. Immunol. 148:2002;267-271.
47. Krause D.S., Ito T., Fackler M.J., Smith O.M., Collector M.I., Sharkis S.J., May W.S. Characterization of murine CD34, a marker for hematopoietic progenitor and stem cells. Blood. 84:1994;691-701.
48. Jackson K.A., Majka S.M., Wulf G.G., Goodell M.A. Stem cells: a minireview. J. Cell. Biochem. 38:2002;1-6. (Suppl.).
49. Osawa M., Hanada K., Hamada H., Nakauchi H. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science. 273:1996;242-245.
50. Torrente Y., Tremblay J.P., Pisati F., Belicchi M., Rossi B., Sironi M., Fortunato F., El Fahime M., D'Angelo M.G., Caron N.J.et al. Intraarterial injection of muscle-derived CD34(+)Sca-1(+) stem cells restores dystrophin in mdx mice. J. Cell Biol. 152:2001;335-348.
51. Mahmud N., Weiss P., Li F., Hoffman R. Primate skeletal muscle contains cells capable of sustaining in vitro hematopoiesis. Exp. Hematol. 30:2002;925-936.
52. Dell'Agnola C., Rabascio C., Mancuso P., Capillo M., Pruneri G., Gobbi A., Minucci S., Ronzoni S., Volorio S., Calabrese L.et al. In vitro and in vivo hematopoietic potential of human stem cells residing in muscle tissue. Exp. Hematol. 30:2002;905-914.
53. Firulli A.B., Olson E.N. Modular regulation of muscle gene transcription: a mechanism for muscle cell diversity. Trends Genet. 13:1997;364-369.
54. Kitzmann M., Fernandez A. Crosstalk between cell cycle regulators and the myogenic factor MyoD in skeletal myoblasts. Cell. Mol. Life Sci. 58:2001;571-579.
55. Miller J.B., Schaefer L., Dominov J.A. Seeking muscle stem cells. Curr. Top. Dev. Biol. 43:1999;191-219.
56. Florini J.R., Ewton D.Z., Roof S.L. Insulin-like growth factor-I stimulates terminal myogenic differentiation by induction of myogenin gene expression. Mol. Endocrinol. 5:1991;718-724.
57. Hasty P., Bradley A., Morris J.H., Edmondson D.G., Venuti J.M., Olson E.N., Klein W.H. Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene. Nature. 364:1993;501-506.
58. Smith C.K., Janney M.J., Allen R.E. Temporal expression of myogenic regulatory genes during activation, proliferation, and differentiation of rat skeletal muscle satellite cells. J. Cell. Physiol. 159:1994;379-385.